Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
मुख्य लेखक: | Rahman, Tasnim |
---|---|
अन्य लेखक: | Azam, Faruque |
स्वरूप: | थीसिस |
भाषा: | English |
प्रकाशित: |
Brac University
2024
|
विषय: | |
ऑनलाइन पहुंच: | http://hdl.handle.net/10361/22174 |
समान संसाधन
-
Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
द्वारा: Paul, Pulock
प्रकाशित: (2024) -
Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
द्वारा: Flora, Sanzida Alam
प्रकाशित: (2024) -
Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
द्वारा: Hoque, Ismoth Ara
प्रकाशित: (2024) -
Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
द्वारा: Karim, Samia Binte
प्रकाशित: (2024) -
Potential of liposomes for the treatment of lung cancer- a review
द्वारा: Mim, Shanzida
प्रकाशित: (2023)